Press Release Merck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Radiotherapy, for Patients With Newly Diagnosed, High-Risk Endometrial Cancer After Surgery With Curative Intent 9 May 2024
Press Release TELUS International reports first quarter 2024 results, delivering robust profitability and cash flow; reiterates full-year outlook 9 May 2024
Press Release Terran Orbital Releases Inaugural Environmental, Social, and Governance Report 9 May 2024
